The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective observational study investigating the impact of immune checkpoint inhibitors for cancer on fertility in males and females of child-bearing age (immuno-fertility).
 
Rachel J Keogh
Travel, Accommodations, Expenses - MSD
 
David O'Reilly
Travel, Accommodations, Expenses - MSD; SERVIER
 
Sam Jonathan Marks
No Relationships to Disclose
 
Maebh Horan
No Relationships to Disclose
 
Rachel Elebert
No Relationships to Disclose
 
Louise Glover
No Relationships to Disclose
 
Maciej Milewski
No Relationships to Disclose
 
Keith Egan
No Relationships to Disclose
 
Bryan T Hennessy
No Relationships to Disclose
 
William Grogan
Travel, Accommodations, Expenses - Bayer
 
Patrick G. Morris
No Relationships to Disclose
 
Oscar S. Breathnach
No Relationships to Disclose
 
Adrian Gerard Murphy
No Relationships to Disclose
 
Mary Wingfield
No Relationships to Disclose
 
David A Crosby
No Relationships to Disclose
 
Jarushka Naidoo
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Merck KGaA; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Roche/Genentech; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb